Inovio Pharmaceuticals
INO
#8871
Rank
HK$1.15 B
Marketcap
HK$16.81
Share price
-0.46%
Change (1 day)
-46.35%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): -HK$22.45

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$22.41. In 2024 the company made an earnings per share (EPS) of -HK$30.74 an increase over its 2023 EPS that were of -HK$47.39.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$22.45-26.98%
2024-HK$30.74-35.14%
2023-HK$47.39-56.62%
2022-HK$109.25-19.54%
2021-HK$135.7935.9%
2020-HK$99.91-11.57%
2019-HK$112.9915.24%
2018-HK$98.05-2.78%
2017-HK$100.856.93%
2016-HK$94.31134.88%
2015-HK$40.15-29.51%
2014-HK$56.96-57.34%
2013-HK$133.53146.55%
2012-HK$54.1620.83%
2011-HK$44.82-29.41%
2010-HK$63.50-48.48%
2009-HK$123.2610%
2008-HK$112.0511.11%
2007-HK$100.85-41.3%
2006-HK$171.81-66.91%
2005-HK$519.18110.61%
2004-HK$246.51-61.63%
2003-HK$642.43186.67%
2002-HK$224.10
2001N/A-100%
2000-HK$179.28-63.64%
1999-HK$493.03

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$13.38-159.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$81.23-462.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-HK$9.73-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.27-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
HK$59.09-363.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$27.98-224.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
HK$50.73-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA